Because there is no apparent correlation of the predominant frequency distribution with the damage distribution, we may conclude that the damage concentration is not primarily controlled by spatial differences in the local site effects, specifically featured in the DCA.
It can be observed that for both SD and HD, the interaction term is predominant (SD: correlation = 0.94; HD: correlation = 0.92).
It is worth noting that the event pair shown in Fig. 3, as well as other pairs which are not shown, are characterized by a large S-phase and small P-phase, with the S-phase being the predominant contributor to the negative cross-correlation coefficient, and the P-phase unstable as per positive or negative cross correlation.
We observe in the above approximation the presence of the predominant term represented by the sum-correlation Γm,u(b) without CFO and the first and the second derivatives of Γ m, u CFO ( b, δ f ) which are multiplied by the CFO value δ f and δ f2, respectively.
It would, however, be difficult to postulate a spurious source of bias to explain such fluctuations and correlations for which the predominant component was evident not only at low frequency and large scales but also with each of the different elements examined.
If expression breadth is the predominant force affecting codon usage, a spurious correlation between codon bias and gene expression is more likely to be generated.
We cannot see much correlation of heavy damage to the predominant frequency.
In older adults correlation between clinical classification and the predominant neuropathology seen at autopsy is poor [ 10].
Correlations reveal that topography is the predominant factor affecting the spatial pattern of AOD, as compared to the urban land use and vegetation.
The absence of any similar correlation in BPH where DHT becomes the predominant hormone may suggest an indirect role for testosterone in the regulation of growth factor production.
There was no significant correlation between the presence of SIBO and the predominant bowel pattern or concurrent use of tegaserod, proton pump inhibitors, or opiate analgesics.
